Mar 1, 2017 • 7:30 am EST Corbus Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 23, 2017 • 8:05 am EST Corbus Pharmaceuticals Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation in Alveolar Macrophages from Cystic Fibrosis Patients
Feb 21, 2017 • 7:30 am EST Corbus Pharmaceuticals to Host Research and Development Day on March 13, 2017
Jan 17, 2017 • 7:30 am EST Corbus Pharmaceuticals Receives Orphan Designation for JBT-101 for the Treatment of Systemic Sclerosis in the European Union